IL-17A plays an important role in induction of type 2 diabetes and its complications |
| |
| Affiliation: | 1. Division of Neurodegenerative Disorders, St Boniface Hospital Research Centre, Winnipeg, MB R2H 2A6, Canada;2. Department of Pharmacology & Therapeutics, University of Manitoba, Winnipeg, MB R3E 0T6, Canada;1. Semiconductor Physics, Technische Universität Chemnitz, D-09107 Chemnitz, Germany;2. Institute for Print and Media Technology, Technische Universität Chemnitz, D-09107 Chemnitz, Germany;3. Coordination Chemistry, Technische Universität Chemnitz, D-09107 Chemnitz, Germany;4. Inorganic Chemistry, Technische Universität Chemnitz, D-09107 Chemnitz,Germany;5. Solid Surface Analysis, Technische Universität Chemnitz, D-09107 Chemnitz, Germany |
| |
| Abstract: | ![]()
Type 2 diabetes (T2D) is the most prevalent metabolic disease worldwide. Previous studies revealed that immune responses, genetic factors, and inflammatory processes played important roles in the pathogenesis and complications of T2D. It has been documented that some people who have T2D are suffering from serious organ-specific pathophysiological conditions including nephropathy and retinopathy. The mechanisms responsible for progression of the disease and its long-term complications are yet to be clarified. IL-17A as a pro-inflammatory cytokine has a dual function, inducing early immune responses against infections and participating in autoimmunity and destructive inflammatory conditions. Therefore, the aim of this review was to address the recent information regarding the status and association of IL-17A with T2D and its related disorders. |
| |
| Keywords: | IL-17A Type 2 diabetes Immune responses Long-term complications |
| 本文献已被 ScienceDirect 等数据库收录！ |
|
